Alphabet To Fund Development Of An Injectable Treatment For Heart Disease

Alphabet is putting money into the research of life sciences through the company’s division of health-technology Verily and its division of investment GV. Both Verily and GV would be working together with Verve Therapeutics which is a start-up with a goal of reducing heart disease’s risk in people. Verve is developing a treatment which would… Continue reading Alphabet To Fund Development Of An Injectable Treatment For Heart Disease